KinDex Pharmaceuticals, Inc. — Form D/A
KinDex Pharmaceuticals, Inc. of Cambridge, MA, a company, filed a Form D amendment with the SEC on 2015-03-09. The offering totals $10.0M, of which $5.5M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2015-03-09
- Form: D/A
- Accession: 0001602462-15-000001
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $10.0M
- Amount sold: $5.5M
- Remaining: $4.5M
- Investors: 6
- Date of first sale: 2014-03-04
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-213543
Issuer
- Name: KinDex Pharmaceuticals, Inc.
- CIK: 0001602462
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2009
- Address: 110 Coolidge Hill, Cambridge, MA, 02138
- Phone: 617-803-5499
Officers, directors & promoters (13)
| Name | Role | Location |
|---|
| Lincoln A Bouillon | Executive Officer | Seattle, WA |
| MICHAEL J HIGGINS | Director | CAMBRIDGE, MA |
| MICHAEL J HIGGINS | Executive Officer | CAMBRIDGE, MA |
| Jeffrey S Bland | Director | Cambridge, MA |
| Jeffrey S Bland | Executive Officer | Cambridge, MA |
| Brent S Eck | Director | Cambridge, MA |
| Jeffrey J Katke | Director | Cambridge, MA |
| Paul J Schimmel | Director | Cambridge, MA |
| Dennis J Ausiello | Director | Cambridge, MA |
| Lincoln J Bouillon | Executive Officer | Seattle, WA |
| Dennis A Ausiello | Director | Seattle, WA |
| Neile A Grayson | Executive Officer | Seattle, WA |
| Roger S Colman | Director | Seattle, WA |
Other filings by this issuer (4)
More